. Normalization of CSF pTau measurement by Aβ40 improves its performance as a biomarker of Alzheimer's disease. Alzheimers Res Ther. 2020 Aug 15;12(1):97. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.